A new vaccine technology based on messenger RNA is reported to be effective in animals with influenza A. Data from the studies has been published online in Nature Biotechnology. The vaccines were developed by CureVac GmbH. ---Subscribe to MedNous to access this article--- Clinical Research Company News
